Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination.

Authors
Category Primary study
JournalNeurology
Year 2004
The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. Following DAC, 38.7% of the participants developed headaches. The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches.
Epistemonikos ID: 545c71069ffbecf3fe9cb41c34bc2c7472297379
First added on: May 13, 2022